Status:
COMPLETED
The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study
Lead Sponsor:
AstraZeneca
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
50-80 years
Phase:
PHASE3
Brief Summary
To investigate the effect of rosuvastatin compared to placebo on the aortic stiffness in hemodialysis patients as measured by pulse wave velocity (at 3, 6 and 12 months)
Eligibility Criteria
Inclusion
- Signed informed consent, between 50 and 80 years of age, end stage renal failure patients receiving hemodialysis
Exclusion
- Received statins within past 6 months, a clear indication for use of lipid altering drug, contra indication for lipid altering drug, history of statin induced myopathy items in very
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
End Date :
October 1 2008
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00240279
Start Date
January 1 2003
End Date
October 1 2008
Last Update
November 19 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Nieuwegein, Netherlands